Genetic clues could refine lymphoma treatment
NCT ID NCT07181785
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 19 times
Summary
This study looked back at tissue samples from 555 people with aggressive B-cell lymphomas to find specific genetic changes. The goal was to see if these changes could help doctors better classify the disease and choose the best treatments. The research focused on understanding, not testing a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS San Raffaele Hospital
Milan, Italy
Conditions
Explore the condition pages connected to this study.